Georg Andreas Schett
Impact in
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Immunology top 0.02%
- Psoriasis: Treatment and Pathogenesis
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
- Rheumatology 440
- Rheumatoid Arthritis Research and Therapies 240
- Spondyloarthritis Studies and Treatments 132
- Systemic Lupus Erythematosus Research 92
- Immunology 265
- Co-authors
- Iain B. McInnes (21 shared papers)Jochen Zwerina (112 shared papers)Jörg Distler (135 shared papers)Oliver Distler (78 shared papers)Bernhard Manger (73 shared papers)Gerhard Krönke (84 shared papers)Martin Herrmann (89 shared papers)Jürgen Rech (102 shared papers)
- Journals
- Annals of the Rheumatic Diseases (202 papers)Lara D. Veeken (54 papers)Arthritis Research & Therapy (47 papers)Arthritis & Rheumatology (36 papers)Frontiers in Immunology (31 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Georg Andreas Schett
1.1k papers receiving 78.6k citations
Georg Andreas Schett's Hit Papers
Peers
Comparison fields: 5 of 199
- Rheumatology 26.2k
- Immunology 20.2k
- Hematology 5.8k
- Orthopedics and Sports Medicine 3.8k
- Oncology 10.2k
Countries citing papers authored by Georg Andreas Schett
This map shows the geographic impact of Georg Andreas Schett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Andreas Schett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Andreas Schett more than expected).
Fields of papers citing papers by Georg Andreas Schett
This network shows the impact of papers produced by Georg Andreas Schett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Andreas Schett. The network helps show where Georg Andreas Schett may publish in the future.
Co-authors
The 25 scholars most cited alongside Georg Andreas Schett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.1k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Pathogenesis of Rheumatoid Arthritis Hit paper breakdown → | 2011 | 4434 |
| 2 | Cytokines in the pathogenesis of rheumatoid arthritis Hit paper breakdown → | 2007 | 2107 |
| 3 | Pathogenetic insights from the treatment of rheumatoid arthritis Hit paper breakdown → | 2017 | 1106 |
| 4 | Dickkopf-1 is a master regulator of joint remodeling Hit paper breakdown → | 2007 | 1101 |
| 5 | Trial of Tocilizumab in Giant-Cell Arteritis Hit paper breakdown → | 2017 | 990 |
| 6 | Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines Hit paper breakdown → | 2014 | 814 |
| 7 | Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus Hit paper breakdown → | 2022 | 752 |
| 8 | Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis Hit paper breakdown → | 2012 | 744 |
| 9 | Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment Hit paper breakdown → | 2012 | 739 |
| 10 | EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update Hit paper breakdown → | 2020 | 733 |
| 11 | European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update Hit paper breakdown → | 2016 | 724 |
| 12 | CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up Hit paper breakdown → | 2024 | 657 |
| 13 | Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss Hit paper breakdown → | 2017 | 618 |
| 14 | Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin Hit paper breakdown → | 2012 | 610 |
| 15 | Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer Hit paper breakdown → | 2016 | 594 |
| 16 | Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis Hit paper breakdown → | 2018 | 590 |
| 17 | 2002 | 483 | |
| 18 | 2010 | 471 | |
| 19 | Locally renewing resident synovial macrophages provide a protective barrier for the joint Hit paper breakdown → | 2019 | 470 |
| 20 | 2008 | 457 |
About Georg Andreas Schett
Georg Andreas Schett is a scholar working on Rheumatology, Immunology, Oncology, Hematology and Pathology and Forensic Medicine, having authored 1.1k papers that have together received 80.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (240 papers), Spondyloarthritis Studies and Treatments (132 papers), Bone Metabolism and Diseases (125 papers), Systemic Lupus Erythematosus Research (92 papers), Systemic Sclerosis and Related Diseases (76 papers), Autoimmune and Inflammatory Disorders Research (62 papers), Bone health and treatments (56 papers) and Monoclonal and Polyclonal Antibodies Research (50 papers). The work is most often cited by research in Rheumatology (26.2k citations), Immunology (20.2k citations), Hematology (5.8k citations), Orthopedics and Sports Medicine (3.8k citations) and Oncology (10.2k citations). Georg Andreas Schett has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Iain B. McInnes, Jochen Zwerina, Jörg Distler, Oliver Distler, Bernhard Manger, Gerhard Krönke, Martin Herrmann, Jürgen Rech, Kurt Redlich and Markus Friedrich Neurath. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Research & Therapy, Arthritis & Rheumatology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.